CAS 269718-83-4: Pardoprunox hydrochloride
Formula:C12H15N3O2·ClH
InChI:InChI=1S/C12H15N3O2.ClH/c1-14-5-7-15(8-6-14)10-4-2-3-9-11(10)17-12(16)13-9;/h2-4H,5-8H2,1H3,(H,13,16);1H
InChI key:InChIKey=NQRIKTDKFHAOKC-UHFFFAOYSA-N
SMILES:O=C1OC2=C(C=CC=C2N1)N3CCN(C)CC3.Cl
Synonyms:- 2(3H)-Benzoxazolone, 7-(4-methyl-1-piperazinyl)-, hydrochloride (1:1)
- 2(3H)-Benzoxazolone, 7-(4-methyl-1-piperazinyl)-, monohydrochloride
- DU 126891 hydrochloride
- Pardoprunox hydrochloride
- SLV 308 hydrochloride
- Slv-308
- Sme-308
Sort by
Found 5 products.
Pardoprunox Hydrochloride
CAS:Controlled ProductApplications Pardoprunox Hydrochloride is an antiparkinsonian drug currently under development by Solvay for the treatment of Parkinson's disease. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Glennon, Jeffrey C., et al.: Synapse, 60, 599 (2006); Wolf, William A., et al.: Current Opinion in Investigational Drugs, 4, 878 (2003); Tayarani-Binazir, K., et al.: Exp. Neurol.: 226, 320 (2010)Formula:C12H15N3O2·ClHColor and Shape:NeatMolecular weight:269.727Pardoprunox hydrochloride
CAS:Pardoprunox hydrochloride is a drug that belongs to the class of 5-HT1A receptor agonists. It has been shown to be effective in the treatment of autoimmune diseases, such as multiple sclerosis. Pardoprunox hydrochloride also has a variety of other effects on the central nervous system, including locomotor activity and dopamine levels. It is metabolized by CYP3A4, which may lead to metabolic disorders. Clinical studies have shown pardoprunox hydrochloride to be effective in treating Parkinson's disease and cancer.Formula:C12H16ClN3O2Purity:Min. 95%Molecular weight:269.73 g/molPardoprunox hydrochloride
CAS:Pardoprunox hydrochloride (SLV-308 hydrochloride) is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist, D2 (pKi = 8.1)Formula:C12H16ClN3O2Purity:98.73% - 99.13%Color and Shape:SolidMolecular weight:269.73
